Artivion Overview
- Year Founded
-
1984
- Status
-
Public
- Employees
-
1,800
- Stock Symbol
-
AORT
- Investments
-
11
- Share Price
-
$18.53
- (As of Thursday Closing)
Artivion General Information
Description
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Contact Information
Website
www.artivion.comCorporate Office
- 1655 Roberts Boulevard, North West
- Kennesaw, GA 30144
- United States
Corporate Office
- 1655 Roberts Boulevard, North West
- Kennesaw, GA 30144
- United States
Artivion Timeline
Artivion Stock Performance
As of 19-Nov-2026, Artivion’s stock price is $18.53. Its current market cap is $904M with 48.8M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $18.53 | $18.54 | $18.11 - $48.25 | $904M | 48.8M | 670K | -$0.36 |
Artivion Financials Summary
As of 30-Sep-2026, Artivion has a trailing 12-month revenue of $482M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,443,268 | 2,349,334 | 1,505,432 | 1,037,971 |
| Revenue | 481,876 | 441,330 | 388,537 | 354,004 |
| EBITDA | 41,129 | 63,057 | 49,501 | 25,712 |
| Net Income | (17,593) | 9,768 | (13,359) | (30,690) |
| Total Assets | 1,042,088 | 884,796 | 789,101 | 792,397 |
| Total Debt | 407,027 | 257,614 | 362,258 | 358,341 |
Artivion Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Artivion Comparisons
Industry
Financing
Details
Artivion Competitors (33)
One of Artivion’s 33 competitors is Merit Medical Systems, a Corporation company based in South Jordan, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merit Medical Systems | Corporation | South Jordan, UT | ||||
| Anteris Technologies | Corporation | Eagan, MN | ||||
| Orthofix Medical | Formerly PE-Backed | Lewisville, TX | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Atricure | Formerly VC-backed | Mason, OH |
Artivion Patents
Artivion Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3094812-A1 | Central nervous system localized hypothermia apparatus and methods | Pending | 22-Mar-2018 | ||
| WO-2019183464-A1 | Central nervous system localized hypothermia apparatus and methods | Inactive | 22-Mar-2018 | ||
| AU-2017206020-A1 | Human placental tissue graft products, methods, and apparatuses | Active | 08-Jan-2016 | ||
| AU-2017206020-B2 | Human placental tissue graft products, methods, and apparatuses | Active | 08-Jan-2016 | ||
| AU-2021245207-A1 | Human placental tissue graft products, methods, and apparatuses | Inactive | 08-Jan-2016 | A61L27/60 |
Artivion Signals
Artivion Investments & Acquisitions (11)
Artivion’s most recent deal was a Merger/Acquisition with Endospan for . The deal was made on 18-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Endospan | 18-May-2026 | Merger/Acquisition | Surgical Devices | ||
| Ascyrus Medical | 02-Sep-2020 | Merger/Acquisition | Therapeutic Devices | ||
| Jotec | 01-Dec-2017 | Merger/Acquisition | Surgical Devices | ||
| Genesee BioMedical (PhotoFix Surgery Product) | 14-Apr-2016 | Corporate Asset Purchase | Buildings and Property | ||
| On-X | 20-Jan-2016 | Merger/Acquisition | Surgical Devices |
Artivion ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
31.78 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Artivion Exits (4)
Artivion’s most recent exit was on 27-Mar-2014 from CryoLife (ProCol). The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CryoLife (ProCol) | 27-Mar-2014 | Completed |
|
||
| ValveXchange | 01-Jan-2012 | Completed |
|
||
| ValveXchange | 01-Jan-2012 | Completed |
|
||
| ValveXchange | 01-Jul-2011 | Corporate | Completed |
Artivion Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Endospan | Herzliya, Israel | 2009 | |
| Hemosphere | Eden Prairie, MN | 1998 |
Artivion FAQs
-
When was Artivion founded?
Artivion was founded in 1984.
-
Where is Artivion headquartered?
Artivion is headquartered in Kennesaw, GA.
-
What is the size of Artivion?
Artivion has 1,800 total employees.
-
What industry is Artivion in?
Artivion’s primary industry is Surgical Devices.
-
Is Artivion a private or public company?
Artivion is a Public company.
-
What is Artivion’s stock symbol?
The ticker symbol for Artivion is AORT.
-
What is the current stock price of Artivion?
As of 19-Nov-2026 the stock price of Artivion is $18.53.
-
What is the current market cap of Artivion?
The current market capitalization of Artivion is $904M.
-
What is Artivion’s current revenue?
The trailing twelve month revenue for Artivion is $482M.
-
Who are Artivion’s competitors?
Merit Medical Systems, Anteris Technologies, Orthofix Medical, Medtronic, and Atricure are some of the 33 competitors of Artivion.
-
What is Artivion’s annual earnings per share (EPS)?
Artivion’s EPS for 12 months was -$0.36.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process